GSK-2018682
Kwa utafiti wa kisayansi tu, sio kwa wagonjwa.
Maelezo ya Bidhaa
Lebo za Bidhaa
| Ukubwa wa Pakiti | Upatikanaji | Bei (USD) |
Jina la Kemikali:
4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid
Msimbo wa SMILES:
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
Msimbo wa InChi:
InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5 -3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1 -2H3,(H,28,29)
Ufunguo wa InChi:
NFIGDBFIDKDNIG-UHFFFAOYSA-N
Neno muhimu:
1034688-30-6;CAS:1034688-30-6;CAS:1034688-30-6;GSK-2018682;GSK 2018682;GSK2018682; 2018682
Umumunyifu:Mumunyifu katika DMSO
Hifadhi:0 - 4 C kwa muda mfupi (siku hadi wiki), au -20 C kwa muda mrefu (miezi).
Maelezo:
GSK2018682 ni agonisti wa vipokezi vya S1P1 na S1P5.
Lengo: Agonists kwa wapokeaji wa S1P1 na S1P5
![(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1- f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol](http://www.caerulumpharm.com/uploads/微信截图_20220802163212-300x280.png)
